Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC116

Ibrutinib, eða lyfjafræðilega nothæft salt þar af

  • Status:
    Veitt
  • Application date:
    8.4.2015
  • Application published:
    15.5.2015
  • Grant published:
    15.3.2016
  • Max expiry date:
    22.4.2030
  • Next due date:
    31.12.2026
  • Medicine name:
    IMBRUVICA
  • Medicine for children:
    Yes

Timeline

Today
8.4.2015Application
15.5.2015Publication
15.3.2016Registration
22.4.2030Expires

Marketing license

  • IS authorization number:
    EU/1/14/945/001-002
  • Date:
    18.11.2014
  • Foreign authorization number:
    EU/1/14/945
  • Date:
    21.10.2014

Owner

  • Name:
    Pharmacyclics LLC
  • Address:
    1 North Waukegan Road, North Chicago, IL 60064 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 10.10.2025

Upload documents